Excerpts

The PMN-MDSC levels correlated negatively at C Malaria with the subsequent lymphocyte circulating values at C Treat2 and reached borderline significance at C Treat3 (Spearman's rank correlation p < 0.05 and p = 0.056, respectively, Figures 5B,C ), but did not correlate with the lymphocyte levels at C Malaria ( p = 0.09, data not shown).

While rhPRG4 treatment showed a trend towards a reduction in PL IL-1β at 24h in Prg4 GT/GT animals, this trend was not statistically significant ( p>0.05 ), due to a high degree of variability in calculated IL-1β concentrations in specimens from the same experimental group.

In Figure 3A , there is a clear trend of increase ( p <0.05) in Chiu’s score and a sharp decrease in mucin secretion of the LPS group compared with the control group.

Meanwhile, studies with higher proportions of patients with AFP > 400 showed a borderline significant trend toward elevated HRs for PFS ( p = 0.05).

According to stratified analysis results, it was possible that female, age <40, Non-Hispanic White people, more than high school, single status, high group of PIR, owned housing, BMI≥28, smoke≥100 cigarettes in life, without hypertension, and with diabetes had lower blood eosinophil counts, with increasing serum folate concentrations displaying a significant trend (p<0.05).

Compared to the model group, the LF-EA group showed a decreasing trend in uterine mass ( P > 0.05), while the HF-EA group demonstrated reductions in uterine mass ( P < 0.05), both the LF-EA group and the HF-EA group showed a trend towards reduced uterine index, transverse diameter of the uterine horns, kidney index, and ovary index ( P > 0.05).

The correlation between total infection frequency and the infection frequency of tat/rev/RRE + proviruses in DN cells approached significance (r=0.5, 95% CI: -0.01, 0.8, p=0.05; Supplementary Figure 3A ), while no significant correlation was observed between total infection frequency and the infection frequency of tat/rev/RRE + proviruses in CTLA-4 + cells (r=0.25, 95% CI: -0.32, 0.68, p=0.37; Supplementary Figure 3C ).

There was a trend towards the transition period being more stressful for patients who attend at least two other hospital specialists, and for those without any affected family members, but this did not reach statistical significance (fisher exact value 0.0613 in both cases, significant at p <0.05).

We used Ingenuity Pathway Analysis (IPA) to investigate the relationship between highly significant genes (adjusted P value <0.05 and absolute fold-change ≥2) in SARS-CoV-2-infected Huwe1 KD cells compared to virus-infected control cells.

Baseline IL-6 ( Table 4 , down) showed a borderline significant positive association with attention at baseline (TMT-A: β = 0.360, p = 0.050), which persisted as a trend at 5 years (β = 0.996, p = 0.052) and reached significance at 10 years (β = 0.568, p = 0.020).

Additionally, the LF-EA group exhibited an increasing trend in spleen index ( P > 0.05), whereas the HF-EA group showed a significant increase in spleen index compared to the LF-EA group ( P < 0.01).

The parameter B was negatively associated with PFS, with a coefficient of -0.26 and a hazard ratio of 0.773, although the p-value was borderline significant (p< 0.05).

A marginally significant association (p < 0.05) was observed for A, with one-unit increase in A being associated with a 30.4% reduction in the hazard rate, assuming a Weibull distribution. suggesting that higher A values are also associated with a shorter time to response.

Furthermore, after removing the studies conducted at the Renmin Hospital, Wuhan, barring the largest ones for disease severity ( 28 ) and survival status ( 39 ), the SMD remained substantially unchanged, albeit borderline significant (SMD -0.28, 95% CI -0.56 to 0.00, p=0.05; I 2 = 88.2%, p<0.001) ( Figure 4B ).

Interestingly, the only significant predictor of inflammation as diagnosed by pathology was the tCRM score (OR: 1.90, 95% CI: 1.40–2.68, p < 0.001), while having a male donor to female recipient was protective with borderline significance (OR: 0.27, 95% CI: 0.07–0.98, p = 0.05).

neonatal T cells CD8 + T cells RNA-sequencing IL-12 T cell activation neonatal immunity Institut National de la Santé et de la Recherche Médicale 10.13039/501100001677 Ligue Contre le Cancer 10.13039/501100004099 Agence Nationale de la Recherche 10.13039/501100001665 Next, we analyzed the patterns of gene expression changes after TCR or TCR-IL12 stimulation, considering only highly significant differential genes (adjusted p < 0.05 and log 2 fold change ≥ 2) after TCR or TCR-IL12 stimulation ( Figure 2A ).

An increasing trend was seen for anti-NP antibodies, Mw-HNM inducing highest anti-NP titers ( p < 0.05).

A correlation of borderline significance was found between FPW and age at biopsy ( r = 0.43; P = 0.05).

However, the association between detectable properdin and graft failure became borderline significant after further adjustment for proteinuria (HR, 1.47; 95% CI 0.85–2.54; P = 0.05).

Compared with the FLIPI model for OS prediction, FLIPI-SII showed improved reclassification and discrimination at 3 years (NRI = 0.245, p = 0.034; IDI = 0.013, p = 0.028), and maintained a favorable trend at 5 years (NRI = 0.247, p = 0.050; IDI = 0.018, p = 0.096).

As shown in Figure 6C , RA-treated DCs showed a trend ( P = 0.05) for increased spreading on E-cadherin.

This finding was validated by western blot at protein level (Figures 4 C,D) finding marginally significant differences when comparing risk and protective genotypes at basal levels ( p = 0.05), but not after stimulation.

Similar to NK1.1 activation, we observed a modestly reduced frequency of Stat1 β/β NK cells producing IFNγ compared to their WT counterparts, although this did not reach statistical significance with the threshold set at p < 0.05 ( Figure 3F ).

The DeLong test confirmed that the combined model’s AUC was significantly higher than that of HDL ( P = 0.006) and showed a trend toward being higher than SIR max ( P = 0.050).

A similar B-cell (CD20) and fibroblast (CD90) content was present in all tissues tested ( Figure 4B e,f), while a decreasing trend for T cells (CD3) could be detected in the adalimumab scFv-Fc ( p < 0.05 and p = 0.05) and A7/adalimumab ( p = 0.1 and p = 0.05) treatment groups compared to control and E2/adalimumab ( Figure 4B c).